Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
9 papers
Recent·Most cited
H. Kim, S. C. Min, D. B. Lee, J. H. Jeong, E. J. Kim, J. Y. Maeng, J. H. Seok, J.-H. Lee, Y. Jang, U. S. Jang, T. Ysenbaert, J. P. P. Catani, J. Lee, Y. Lee, Y. K. Kim, , K. H. Kim
This study develops a nanoparticle vaccine displaying conserved influenza HA epitopes, inducing broad neutralizing antibodies against multiple viral subtypes.
bioRxiv · Apr 10, 2024 · PreprintBioengineering
C. R. Gurbatri, G. Radford, L. Vrbanac, C. Coker, J. Im, S. R. Taylor, Y. Jang, A. Sivan, K. Rhee, A. A. Saleh, T. Chien, F. Zandkarimi, I. Lia, T. R. Lannagan, T. Wang, , T. Danino
This paper demonstrates the use of engineered probiotics to detect and treat colorectal cancer by monitoring their colonization and delivering therapeutic molecules.
bioRxiv · Apr 3, 2023 · PreprintBioengineering
Y. Jang, H. Cho, J. Chun, K. Park, A. Nowakowska, J. Kim, H. Lee, C. Lee, Y. Han, H.-J. Lee, H.-Y. Shin, Y. B. Kim
This paper develops a baculoviral DNA vaccine targeting the SARS-CoV2 Delta variant, showing 100% survival against Delta and Omicron in mice, compared to 50% survival with the original vaccine.
bioRxiv · Oct 7, 2022Immunology
K. Myakala, X. Wang, N. V. Shults, B. A. Jones, X. Yang, A. Z. Rosenberg, B. Ginley, P. Sarder, L. Brodsky, Y. Jang, C. H. Na, Y. Chi, X. Zhang, U. Guha, C. Wu, , M. Levi
This study shows that nicotinamide riboside (NR) improves mitochondrial function and reduces inflammation in diabetic kidney disease by enhancing NAD metabolism and inhibiting the cGAS-STING pathway.
bioRxiv · Dec 5, 2021Pathology
r. tapia, B. Brito, M. Saavedra, j. mena, T. Garcia-Salum, R. Rathnasinghe, G. Barriga, K. Tapia, V. Garcia, S. Bucarey, Y. Jang, D. E. Wentworth, M. Torremorell, V. Neira-Ramirez, R. A. Medina
The paper identifies novel human-derived influenza viruses in Chilean pigs, showing zoonotic potential and antigenic drift.
bioRxiv · Jun 8, 2021 · PreprintMicrobiology
T. Y. Kim, S. Jeon, Y. Jang, L. Gotina, J. Won, Y. H. Ju, S. Kim, M. W. Jang, W. Won, M. G. Park, A. N. Pae, S. Han, S. Kim, C. J. Lee
This study shows that platycodin D inhibits SARS-CoV-2 infection by blocking lysosome- and TMPRSS2-driven entry through membrane cholesterol redistribution.
bioRxiv · Dec 22, 2020Pharmacology & Toxicology
H. K. Kim, H. Kim, M. K. Lee, W. H. Choi, Y. Jang, J. S. Shin, J.-Y. Park, K. H. Kim, H. W. Han, M. Kim, Y. C. Lim, J. Yoo
This study established tonsil epithelial cell-derived organoids and demonstrated their feasibility as an ex vivo model for SARS-CoV-2 infection.
bioRxiv · Aug 6, 2020 · PreprintMicrobiology
bioRxiv · Aug 4, 2020Microbiology
B. L. Rambo-Martin, M. W. Keller, M. M. Wilson, J. M. Nolting, T. K. Anderson, A. L. Vincent, U. Bagal, Y. Jang, E. B. Neuhaus, C. T. Davis, A. S. Bowman, D. E. Wentworth, J. R. Barnes
The paper describes using field-derived nanopore sequencing to identify a novel swine influenza A virus that posed a pandemic risk, leading to the development of a vaccine candidate and real-time public health response.
bioRxiv · Mar 21, 2019 · PreprintMicrobiology